quizartinib 26.5 MG Oral Tablet [Vanflyta]
RxNorm concept 2643064, branded drug (sbd). Prescribable name: VANFLYTA 26.5 MG Oral Tablet.
- RxCUI
- 2643064
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2643064 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Vanflyta 26.5 MG (equivalent to 30 MG quizartinib dihydrochloride) Oral Tablet; Vanflyta 26.5 MG Oral Tablet
Related concepts
- quizartinib 26.5 MG (SCDC, consists of)
- quizartinib 26.5 MG [Vanflyta] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Vanflyta (BN, has ingredient)
- quizartinib 26.5 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2643064 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2643064 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2643064. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.